Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection

Vulturar, DM; Neag, MA; Vesa, SC; Maierean, AD; Gherman, D; Buzoianu, AD; Orasan, OH; Todea, DA

Neag, MA (通讯作者),Iuliu Hatieganu Univ Med & Pharm, Pharmacol Toxicol & Clin Pharmacol Dept, Cluj Napoca 400337, Romania.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022; 23 (22):

Abstract

The infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) generated many challenges to find an effective drug combination for ho......

Full Text Link